Dr. Eber Brain Hospital
Surgical treatment of epilepsy in China typically costs from $18,500 to $48,000. The final price depends on the surgical technique, the depth of brain intervention, and the hospital tier. In the US, similar procedures cost around $77,500 on average. Patients save around 57% compared to US prices. Standard inclusions often cover pre-surgical diagnostics like 3.0T MRI and EEG monitoring.
Bookimed Expert Insight: The smartest move in China is targeting JCI-accredited "Class A Level III" facilities. Yanda International Hospital holds this highest national rank and serves millions of patients annually. This designation ensures top-tier safety standards at a fraction of Western costs. Look for experts like Dr. Shao Ming. He introduced the propofol Wada test to China after training at Harvard.
| China | Turkey | Austria | |
| Surgical treatment of epilepsy | from $18,500 | from $15,000 | from $30,000 |
| Vagus nerve stimulation | from $23,500 | from $12,000 | from $30,000 |
| Medication treatment for epilepsy | from $2,100 | from $500 | from $1,100 |
| Multiple subpial transections | from $21,500 | from $20,610 | - |
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6-14
Week 3-4
Week 5-6
Week 7+
Please note that each patient"s case is individual and may vary. Decisions about the exact course of treatment should be made in cooperation with your healthcare provider.
Prof. Sun Chen Yang combines traditional Chinese medicine with surgical epilepsy treatment at Eber Perennial Brain Hospital.
Professor Yi Yao, MD, is Chief of the Epilepsy Center. He is an internationally recognized expert in functional neurology and neurosurgery. He specializes in complex epilepsy care for children and adults. He has over 35 years of experience.
Clinical expertise: brain mapping; drug-resistant epilepsy; emergency seizure care; advanced neurosurgical planning; microsurgery for tumors and vascular disease.
Professional leadership: Standing Council Member, China Association Against Epilepsy; Vice Chairman, Epilepsy Surgery Foundation; Committee Member, Pediatric Neurosurgery; Vice President, Fujian Epilepsy Association.
Dr. Shao Ming pioneered propofol use for the Wada test in China – enhancing epilepsy surgery safety. He leads at Eber Perennial Brain Hospital with 50+ published studies.
Professor ZHENG Wei Hong is Director of the Department of Neurology and the discipline leader. He previously served as Director of Neurology at Xiamen University Affiliated Zhongshan Hospital. He is a Professor at Xiamen University and a master's supervisor.
His clinical focus includes etiological investigation, prevention, and treatment of cerebral infarction and cerebral hemorrhage. He also diagnoses and treats complex neurological diseases, including epilepsy, neuroimmunological and neuromuscular disorders (myasthenia gravis, multiple sclerosis), and Parkinson's disease.
Appointments: He serves as a committee member of the Neuroimmunology Group (Chinese Medical Association Neurology Branch), the Immunology Branch (Chinese Stroke Association), Neurorestoration (Chinese Medical Doctor Association), and Cognitive Impairment (Chinese Geriatrics Society). He is on the Standing Committee of the Expert Committee of Stroke Screening and Prevention Engineering Base Hospitals (Ministry of Health). He is a member of the Neurology Expert Group, Fujian Provincial Medical Quality Control Center for Stroke and Epilepsy. He is Standing Director of the Fujian Anti‑Epilepsy Association. He is Deputy Group Leader of the Epilepsy and Electroencephalography Group (Fujian Medical Association Neurology Branch). He is Deputy Chairperson of the 1st Committee, Neurology Physicians Branch (Fujian Medical Doctor Association). He is a Standing Committee Member (5th–7th) of the Neurology Branch (Fujian Medical Association). He is Deputy Chairperson of the Neurology Professional Committee (Xiamen Medical Association).
Written by Anna Leonova